Cresemba
Chemical Name | isavuconazonium sulfate |
Dosage Form | Capsule (oral; 186 mg); injection (intravenous; 372 mg) |
Drug Class | Antifungals |
System | Digestive, Skin, Respiratory, Nervous |
Company | Astellas Pharma Inc. |
Approval Year | 2015 |
Indication
- To treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections.